We Need a More Permanent Solution to Inter Partes Review Overreach

U.S. Patent and Trademark Office (USPTO) Director John Squires stated in his Senate confirmation hearing last year that “with born strong patents and robust quality marks we can reclaim America’s primacy, revitalize industry and growth, proudly export our culture, boost national security and improve our lives.” If the goal is to have “born strong patents”, we must be honest about what is born with patents and what is not. For instance, a credible mark of novelty is born with every patent—that much is clear. However, novelty is not just technical newness—it is also market impression. If novelty were only technical newness, people would own patents without their technology ever being used in the market. There would be no point to the patent system. This means that the rest of patents—their assertion power, damages recovery power, term limitation, claim bundling provision, inter partes review (IPR) fee requirement, and more—must also be part of the birth. This is how to create born strong patents.

The Supreme Court Must Revisit Prosecution Laches—And the Industry Should Speak Up

The latest chapter in the long-running saga of inventor Gil Hyatt is beginning to unfold. The current fight is over prosecution laches—and whether the doctrine even exists. In his last appeal to the Federal Circuit, Hyatt argued that prosecution laches is not available in Section 145 proceedings because it is inconsistent with the Patent Act of 1952, as confirmed by recent U.S. Supreme Court rulings in Petrella v. Metro-Goldwyn-Mayer (2014) and SCA Hygiene Products Aktiebolag v. First Quality Baby Products (2017). Whether Hyatt is correct about prosecution laches being inconsistent with the 1952 Patent Act, it is clear that the Supreme Court has unequivocally ruled in both Petrella and SCA that laches simply does not exist when there is a statutorily prescribed timeframe to act.

Patent Prosecution in the AI-Native Future: How IP Counselors Can Succeed

As discussed in my prior article, the growing adoption and sophistication of assistive AI tools for patent prosecution are paving the way for material business and career impacts, such as decreased prosecution revenue and reduced staffing over the long term. Despite these potential risks, practitioners and enterprises may experience widely differing outcomes due to their client mix, expertise, and capacity to navigate shifting winds to advantage.

IP Innovators: Writer’s Block Is Dead: Drew McElligott on AI in Legal Practice

In the latest episode of IP Innovators, host Steve Brachmann sits down with Drew McElligott, Counsel at Crowell & Moring, to explore how artificial intelligence (AI) is reshaping legal workflows from the inside of a major law firm. While much of the conversation around AI focuses on disruption, McElligott offers a grounded, practitioner-driven perspective: one of the most immediate and impactful changes is how patent attorneys begin drafting. As AI tools become more integrated into legal practice, they are redefining the early stages of patent drafting and eliminating one of the most persistent challenges in writing: the blank page.

Thoughts on Finesse Wireless‘s Framing of Datascope as an ‘Infamous’ Example of Federal Circuit Overreach

In 2008, a medical device company I represented, Datascope Corporation, won a hard-fought victory at the U.S. Court of Appeals for the Federal Circuit. That court reversed a verdict of patent infringement rendered by a federal jury in Baltimore in a suit brought by Johns Hopkins University and its licensee against my client. Johns Hopkins Univ. v. Datascope Corp., 543 F.3d 1342 (Fed. Cir. 2008).

Delaware Court Denies Sony Subsidiary Summary Judgment in Cinemavault Trademark Dispute

The U.S. District Court for the District of Delaware on Tuesday denied a motion for summary judgment in Cinemavault, Inc. v. Gameshow Network, LLC, allowing a trademark infringement and unfair competition lawsuit to proceed to trial. Judge Joel H. Slomsky rejected Gameshow Network, LLC’s arguments that Cinemavault, Inc. failed to continuously use its trademark, that Cinemavault, Inc. was judicially estopped from bringing a likelihood of confusion claim, and that the relevant Lapp factors precluded Cinemavault from establishing a likelihood of confusion between the two marks at issue.

What They Don’t Teach You In School About Corporate Patent Monetization

Each year, companies invest significant financial resources building and maintaining patent portfolios. But instead of contributing to the bottom line, the patent portfolio often evolves into a growing cost center burdened by maintenance fees, prosecution expenses, and legal overhead. The patents protect some of the company’s products, and make nice plaques for the corporate hallways, but serve little other purpose. Patent monetization offers an opportunity to reverse this dynamic. Done correctly, it can transform dormant intellectual property into a durable revenue stream. Done poorly, it can create reputational risk, misaligned incentives, and wasted capital.

IPWatchdog Events

Industry Events

Intellectual Property Conference 2026
March 23 @ 9:45 am - 5:00 pm EDT
PIUG 2026 Joint Annual and Biotechnology Conference
May 19 @ 8:00 am - May 21 @ 5:00 pm EDT
Certified Patent Valuation Analyst Training
May 28 @ 9:00 am - May 29 @ 5:00 pm EDT

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates